Serum ALT activity rose to ≥2 × baseline and ≥2 × ULN in 6 (6.0%) of 101 patients not considered to have developed rifampicin induced liver injury (range 2.1‐3.8 fold rise). The gene discussed is GPT; the disease is injury.